![](/img/cover-not-exists.png)
Phase II study of D.651, an oral vaccine designed to prevent recurrences of vulvovaginal candidiasis
D.A. Levy, J.M. Bohbot, F. Catalan, G. Normier, A.M. Pinel, L. Dussourd d'HinterlandVolume:
7
Year:
1989
Language:
english
DOI:
10.1016/0264-410x(89)90197-7
File:
PDF, 407 KB
english, 1989